MARKET

SCLX

SCLX

Scilex Holding Co
NASDAQ
8.76
-0.46
-4.99%
Opening 14:45 07/16 EDT
OPEN
9.00
PREV CLOSE
9.22
HIGH
9.48
LOW
8.68
VOLUME
22.49K
TURNOVER
--
52 WEEK HIGH
10.43
52 WEEK LOW
6.60
MARKET CAP
74.38M
P/E (TTM)
-0.2223
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SCLX last week (0706-0710)?
Weekly Report · 3d ago
Scilex Portfolio Company Semnur Pharmaceuticals Receives $100M Investment From iHolding In 10M Newly Issued Shares At $10 Per Share
Benzinga · 07/07 10:05
Semnur signs term sheet for $100 million unregistered share sale to iHolding Group at $10 per share
PUBT · 07/07 10:03
SCILEX HOLDING CO - IHOLDING TO INVEST $100 MLN IN NEWLY ISSUED SEMNUR COMMON STOCK
Reuters · 07/07 10:00
SCILEX HOLDING COMPANY ANNOUNCES DREAM BOWL I MEME COIN TOKENS COMMENCE TRADING ON THE BICONOMY EXCHANGE ON JULY 6, 2026
Reuters · 07/06 15:35
What's Going on With Scilex Holding Stock Monday?
Benzinga · 07/06 13:02
Scilex secures major growth capital equity investment
TipRanks · 07/06 10:48
Scilex Says Private Investment Group to Buy $100M in Newly Issued Shares
Dow Jones · 07/06 10:26
More
About SCLX
Scilex Holding Company is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company’s commercial products include ZTlidoO (lidocaine topical system) 1.8% for the relief of neuropathic pain associated with postherpetic neuralgia (PHN); ELYXYB, a ready-to-use oral solution for the acute treatment of migraine, with or without aura, in adults; and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. In addition, it focuses on product candidates, including SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXAO), an epidural injections formulation to treat lumbosacral radicular pain, or sciatica; SP-103 (lidocaine topical system) 5.4%, a ZTlido formulation, for the treatment of acute pain; and SP-104 (4.5 mg, low-dose naltrexone hydrochloride delayed-release capsules) (SP-104) for fibromyalgia treatment.

Webull offers Scilex Holding Co stock information, including NASDAQ: SCLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCLX stock methods without spending real money on the virtual paper trading platform.